Science News

Dr. Diane Bovenkamp speaking at the Geroscience Summit 2019.
Science News
Gains in life expectancy have been accompanied by a rise in age-related diseases, including Alzheimer’s disease, macular degeneration, and glaucoma. Geroscience, as a field, wants to reduce age-related diseases, and BrightFocus is excited about partnering with this interdisciplinary field. .
January 10, 2020
Science News
Geroscience, as a field, seeks to intervene with aspects of aging that increase the risk of disease. In a Q&A, BrightFocus VP of Scientific Affairs Diane Bovenkamp, PhD, thinks that could help find cures for diseases of mind and sight.
January 10, 2020


This brochure discusses the two categories of age-related macular degeneration, diagnosis, risk factors, prevention strategies and treatment.
September 23, 2019
This publication provides information on what glaucoma is, the various forms of glaucoma, tips for lowering risk, how this eye disease is diagnosed and treated, and essential questions to ask your doctor after a diagnosis.
October 4, 2018
Learn about the two forms of age-related macular degeneration (AMD), the importance of early diagnosis, healthy habits that may reduce the risk of developing AMD, and how to monitor your sight if you have this eye disease.
October 3, 2018



The Role of Occupational Therapy in Low Vision

The guest speaker is Joe Kardine, OTR/L, who is an occupational therapist at Thomas Jefferson University Hospital. Mr. Kardine specializes in treating those with vision and cognitive deficits as well as neurologic rehabilitation. View the transcript Print the transcript Listen to the discussion:

March 18, 2020

AMD: Your Questions Answered (February 2020)

The guest speaker is Avnish A. Deobhakta, MD, who is an ophthalmologist and Assistant Professor at the Icahn School of Medicine at Mount Sinai in New York NY. View the transcript Print the transcript Listen to the discussion:

February 26, 2020

Our Story

BrightFocus funds exceptional scientific research worldwide to defeat Alzheimer’s disease, macular degeneration, and glaucoma and provides expert information on these heartbreaking diseases.

Normal brain vs. Alzheimer's brain

Take a look at the formation of amyloid plaques in a brain affected by Alzheimer's compared to a normal brain.

Press Releases

An abstract image of a hand holding a test tube
Press Release
A BrightFocus Foundation-funded project to develop a blood-based screening test for Alzheimer’s disease has passed proof of concept stage and C2N Diagnostics, the company spearheading the development of the test, will move forward to approve use in research and clinical settings, according to a presentation at a major scientific conference.
December 9, 2019
Press Release
BrightFocus is highly encouraged by Biogen’s announcement today that clinical trials of its experimental drug aducanumab reduced cognitive decline in some Alzheimer’s patients through improved cognition, memory, and activities of daily living.
October 22, 2019
Don't miss out.
Receive research updates, inspiring stories, and expert advice
Please enter your first name.
Please enter your last name.
Keep me informed about: *
Please select at least one.
You must select at least one disease category.